Natera Inc
(NAS:NTRA)
$
127.21
-2.46 (-1.9%)
Market Cap: 15.73 Bil
Enterprise Value: 15.59 Bil
PE Ratio: 0
PB Ratio: 18.76
GF Score: 72/100 
Natera Inc at Credit Suisse Healthcare Conference Transcript
Nov 09, 2022 / 06:25PM GMT
Release Date Price:
$37.07
(-12.65%)
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
Great. Well, the green light means we're on. Our next session is Natera. We're lucky to have with us today, Steve Chapman, CEO; Mike Brophy, CFO. I'm Dan Leonard, I cover diagnostics for Credit Suisse. Welcome, Steve. Welcome, Mike.
Steven Leonard Chapman
Natera, Inc. - CEO, President & Director
Thanks for having us.
Michael B. Brophy
Natera, Inc. - CFO
Yes. Thank you.
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
So given the timing, you had Q3 earnings last night, I thought we can kick things off by recapping some of the key highlights from your earnings report.
Steven Leonard Chapman
Natera, Inc. - CEO, President & Director
Yes. So we had a great quarter. We saw strong revenue growth, strong volume growth. We raised guidance again for the third time
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers